• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型酰胺和咪唑类化合物作为强效的造血前列腺素 D 合酶抑制剂。

Novel amide and imidazole compounds as potent hematopoietic prostaglandin D synthase inhibitors.

机构信息

Cayman Chemical Company, Inc., 1180 East Ellsworth Rd., Ann Arbor, MI, USA.

Cayman Chemical Company, Inc., 1180 East Ellsworth Rd., Ann Arbor, MI, USA.

出版信息

Bioorg Med Chem Lett. 2021 Feb 15;34:127759. doi: 10.1016/j.bmcl.2020.127759. Epub 2020 Dec 29.

DOI:10.1016/j.bmcl.2020.127759
PMID:33383152
Abstract

In seeking novel and potent small molecule hematopoietic prostaglandin D synthase (H-PGDS) inhibitors as potential therapies for PGD-mediated diseases and conditions, we explored a series comprising multiple aryl/heteroaryl rings attached in a linear arrangement. Each compound incorporates an amide or imidazole "linker" between the pyrimidine or pyridine "core" ring and the "tail" ring system. We synthesized and screened twenty analogs by fluorescence polarization binding assay, thermal shift assay, glutathione S-transferase inhibition assay, and a cell-based assay measuring suppression of LPS-induced PGD stimulation. Amide analogs show ten-fold greater shift in the thermal shift assay in the presence of glutathione (GSH) versus the same assay run in the absence of GSH. The imidazole analogs did not produce a significant change in thermal shift between the two assay conditions, suggesting a possible stabilization effect of the amide linker in the synthase-GSH-inhibitor complex. Imidazole analog 23, (KMN-010034) demonstrates superior potency across the in vitro assays and good in vitro metabolic stability in both human and guinea pig liver microsomes.

摘要

在寻找新型、有效的小分子造血前列腺素 D 合酶 (H-PGDS) 抑制剂作为治疗 PGD 介导的疾病和病症的潜在疗法时,我们探索了一系列线性排列的多个芳基/杂芳基环组成的化合物。每个化合物在嘧啶或吡啶“核心”环和“尾部”环系统之间都有酰胺或咪唑“连接物”。我们通过荧光偏振结合测定法、热位移测定法、谷胱甘肽 S-转移酶抑制测定法和基于细胞的测定法(测量抑制 LPS 诱导的 PGD 刺激)合成并筛选了二十种类似物。与没有 GSH 的相同测定相比,在存在谷胱甘肽 (GSH) 的情况下,酰胺类似物在热位移测定中显示出十倍的更大位移。咪唑类似物在两种测定条件之间没有产生热位移的显著变化,这表明酰胺连接物在合酶-GSH-抑制剂复合物中可能具有稳定作用。咪唑类似物 23(KMN-010034)在体外测定中表现出优异的效力,并且在人肝微粒体和豚鼠肝微粒体中都具有良好的体外代谢稳定性。

相似文献

1
Novel amide and imidazole compounds as potent hematopoietic prostaglandin D synthase inhibitors.新型酰胺和咪唑类化合物作为强效的造血前列腺素 D 合酶抑制剂。
Bioorg Med Chem Lett. 2021 Feb 15;34:127759. doi: 10.1016/j.bmcl.2020.127759. Epub 2020 Dec 29.
2
Development of a scintillation proximity binding assay for high-throughput screening of hematopoietic prostaglandin D2 synthase.用于造血前列腺素D2合酶高通量筛选的闪烁邻近结合测定法的开发。
Anal Biochem. 2016 Oct 15;511:17-23. doi: 10.1016/j.ab.2016.07.028. Epub 2016 Jul 30.
3
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors.发现喹啉-3-甲酰胺是造血前列腺素 D 合酶 (H-PGDS) 的抑制剂。
Bioorg Med Chem. 2019 Apr 15;27(8):1456-1478. doi: 10.1016/j.bmc.2019.02.017. Epub 2019 Feb 11.
4
Identification of indole inhibitors of human hematopoietic prostaglandin D2 synthase (hH-PGDS).人造血前列腺素D2合酶(hH-PGDS)吲哚抑制剂的鉴定
Bioorg Med Chem Lett. 2015 Jun 15;25(12):2496-500. doi: 10.1016/j.bmcl.2015.04.065. Epub 2015 Apr 28.
5
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors.基于知识的、结构辅助的新型 2-苯基咪唑并[1,2-a]吡啶-6-甲酰胺 H-PGDS 抑制剂的发现。
Bioorg Med Chem Lett. 2021 Sep 1;47:128113. doi: 10.1016/j.bmcl.2021.128113. Epub 2021 May 13.
6
Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.基于片段药物设计产生的新型前列腺素D合酶抑制剂。
J Med Chem. 2008 Apr 10;51(7):2178-86. doi: 10.1021/jm701509k. Epub 2008 Mar 15.
7
Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.脂质运载蛋白型前列腺素D合成酶的口服活性选择性抑制剂AT-56的生化、功能及药理学特性
J Biol Chem. 2009 Mar 20;284(12):7623-30. doi: 10.1074/jbc.M808593200. Epub 2009 Jan 8.
8
Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase.人造血前列腺素D合酶口服选择性抑制剂HQL-79的结构与功能特性
J Biol Chem. 2006 Jun 2;281(22):15277-86. doi: 10.1074/jbc.M506431200. Epub 2006 Mar 17.
9
Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters.人源造血前列腺素 D2 合酶(hH-PGDS)结合口袋的研究:两种水的故事。
Bioorg Med Chem Lett. 2012 Jun 1;22(11):3795-9. doi: 10.1016/j.bmcl.2012.04.004. Epub 2012 Apr 13.
10
Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase.鉴定和表征人造血前列腺素 D2 合酶的新型抑制剂。
Eur J Med Chem. 2010 Feb;45(2):447-54. doi: 10.1016/j.ejmech.2009.10.025. Epub 2009 Oct 23.

引用本文的文献

1
Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model.HPGDS抑制剂PK007的药理学及巨噬细胞调节作用表明,mdx小鼠模型中受杜氏肌营养不良症影响的肌肉疾病严重程度降低。
Skelet Muscle. 2025 Apr 24;15(1):11. doi: 10.1186/s13395-025-00379-1.
2
Computer-Aided Designing Peptide Inhibitors of Human Hematopoietic Prostaglandin D2 Synthase Combined Molecular Docking and Molecular Dynamics Simulation.计算机辅助设计人源造血前列腺素 D2 合酶抑制剂肽的分子对接和分子动力学模拟。
Molecules. 2023 Aug 7;28(15):5933. doi: 10.3390/molecules28155933.